title: [Extracorporeal shock-wave lithotripsy in infants. Study of its repercussions on the renal parenchyma].
abstract: OBJECTIVE
  To evaluate the efficacy of extracorporeal shock-wave lithotripsy (ESWL) in infants (less than 2-years-old) and study the potential long-term renal parenchymal damage by 99 m Tc DMSA renal scan.
  
  
  METHODS
  Between November 1993 and February 1998, 12 children underwent ESWL treatment for kidney and ureter urolithiasis with a Sonolith 3,000 lithotriptor (Technomed-Corp). All children were less than 2-years-old. Evaluation of treatment and its consequences was based on clinical examination, conventional imaging (plain abdominal radiography excretory urogram) and a DMSA renal scan performed 24 hours before ESWL and at least 6 months after treatment.
  
  
  RESULTS
  Treatment was successful in 84.6% of cases, by achieving stone-free status after one session and 100% after 2 sessions. Long-term follow-up (one month to four years) did not reveal any blood pressure or renal function changes. No acquired parenchymal scar was identified. On DMSA renal scan.
  
  
  CONCLUSIONS
  The efficacy of ESWL in treating infant urolithiasis is clearly established. Renal parenchymal damage associated with ESWL did not appear in this study, but long-term follow-up mandatory (blood pressure) and each infant should have a DMSA renal scan before and after ESWL to confirm these preliminary results on a larger series.
authors.affiliation: Service de Chirurgie Urologique Pédiatrique, Fondation Hôpital Saint-Joseph, Paris.
authors.forename: O
authors.initials: O
authors.lastname: Traxer
authors.forename: H
authors.initials: H
authors.lastname: Lottmann
authors.forename: F
authors.initials: F
authors.lastname: Archambaud
authors.forename: B
authors.initials: B
authors.lastname: Helal
authors.forename: B
authors.initials: B
authors.lastname: Mercier Pageyral
mesh_terms: D006801:Humans; D007223:Infant; D007668:Kidney / Q000000981:diagnostic imaging / Q000473:pathology; D007669:Kidney Calculi / Q000628:therapy*; D008096:Lithotripsy / Q000009:adverse effects; D011859:Radiography; D011877:Radionuclide Imaging; D014514:Ureteral Calculi / Q000628:therapy*